hat
Enpak nan relatif nan yon esteroyid anabolizan / Androjenik sou lipid serik se depann sou dòz la, wout nan administrasyon (oral vs injectable), kalite esteroyid (aromatizable oswa ki pa aromatizabl), ak nivo nan rezistans nan metabolism èt. Etid administre 600 mg nan nandrolon decanoate pou chak semèn pou 10 semèn demontre yon rediksyon 26% nan nivo kolestewòl HDL.497 Repwesyon sa a se yon ti kras pi gwo pase sa ki rapòte ak yon dòz egal nan testostewòn enanthate, epi li se nan akò ak syans pi bonè ki montre yon enpak pi piti negatif negatif sou HDL / LDL rapò ak nandrolon nwayo kòm konpare ak testostewòn cypionate.498 Nandrolone injectables, sepandan, ta dwe toujou gen yon enpak siyifikativman pi fèb sou lipid serik pase ajan c-17 alfa alkylated.
eng
The relative impact of an anabolic/androgenic steroid on serum lipids is dependant on the dose, route of administration (oral vs. injectable), type of steroid (aromatizable or non aromatizable), and level of resistance to hepatic metabolism.Studies administering 600 mg of nandrolone decanoate per week for 10 weeks demonstrated a 26% reduction in HDL cholesterol levels.497 This suppression is slightly greate than that reported with an equal dose of testosterone enanthate, and is in agreement with earlier studies showing a slightly stronger negative impact on HDL/LDL ratio with nandrolone decanoate as compared to testosterone cypionate.498 Nandrolone injectables, however, should still have a significantly weaker impact on serum lipids than c-17 alpha alkylated agents.